Gender affirming hormone therapy and transgender women fertility: Histologic predictors of germ cell presence.
Lina Rigodanzo MarinsTiago Elias RositoLúcia Maria KliemannEdison CappHelena von Eye CorletaPublished in: Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia (2024)
Cross-sex hormone treatment affects testicular germ cell presence. Basal membrane length and tubular diameter ratio reduces inter variability of measurements and better exemplify how atrophic seminiferous tubules are. Fertility preservation should be addressed by healthcare providers in order to recognize gender affirming treatment impact on transgender health.